Azithromycin anti inflammatory covid

, 2017), could be generalized to COVID-19. Conclusion: The Cochrane review summarized here found that azithromycin did not reduce mortality or improve clinical outcomes in patients with COVID-19 in the inpatient or outpatient setting Evidence suggests that azithromycin has antiviral activity in bronchial epithelial cells, together with anti-inflammatory and immunoregulatory effects

2024-03-28
    Clotrimazole cream for skin rash
  1. , 2011)